Silicon Labs Sales Rise 22% To $251 Million As Quarterly Profit Returns

Medical revenue hit a company-claimed record, while the pending Texas Instruments purchase prompted a suspension of numerical guidance.

Share
Silicon Labs Sales Rise 22% To $251 Million As Quarterly Profit Returns

Silicon Laboratories, which designs wireless chips and software for connected devices, grew third-quarter sales 22% to $251 million and returned to quarterly profitability. Results accompanying Tuesday’s SEC filing put diluted earnings at $0.26 a share, versus a $0.30 loss a year earlier.

Medical Leads The Growth

Sales also rose 10% from the prior quarter. Medical revenue climbed 48% over that same comparison and more than 300% from a year earlier, reaching what Silicon Labs called a quarterly record. The company attributed the medical gains to customers continuing to increase production using its products.

Growth extended across both markets: Industrial & Commercial revenue reached $141 million, up 20% from a year earlier, while Home & Life brought in $110 million, up 24%. Silicon Labs said distributor inventories dropped to a multi-year low and inventories at end customers were near record lows during the quarter.

Its chips serve devices including industrial sensors, smart meters, home locks and medical monitors. Silicon Labs also supplies development tools, sells through distributors and directly to customers, and relies on outside manufacturers to produce its chips. In fiscal 2025, 91% of revenue came from outside the United States.

Profit Returns, Cash Generation Slows

Operating profit was $8 million, reversing a $12.3 million loss a year earlier, despite operating expenses rising to $145 million from $131.4 million. Gross margin reached 60.8%. Quarterly net income was $8.9 million, compared with a $9.9 million loss.

Adjusted earnings rose 228% to $1.05 per share. That measure excluded stock-based pay, amortization of purchased intangible assets and merger-related costs of $6.9 million, among other adjustments. Adjusted operating profit was $40 million, with adjusted operating expenses of $113 million and gross margin of 61.0%.

The quarterly recovery has not yet produced a profit for the year to date. Silicon Labs lost $17.6 million in the first nine months, compared with $62.2 million in the corresponding 2025 period. Research and development spending reached $276.8 million, up from $263.7 million.

Operations generated $37.2 million in cash over the first nine months, down from $87.4 million a year earlier. The company held $423 million in cash and cash equivalents at quarter-end, compared with $364.2 million at the start of the fiscal year.

Texas Instruments Deal Pauses Guidance

Silicon Labs suspended numerical forecasts because of its previously announced, pending acquisition by Texas Instruments. Management nevertheless offered a positive assessment of orders and customer projects moving into production.

Matt Johnson, president and chief executive officer of Silicon Labs, said, “our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”

Sources